Internal Medicine, Infectious Disease · Fort Worth, TX
NPI
1013982511
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1125 College Ave
Fort Worth, TX, 76104
Phone (817) 810-9810
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.5M
77,897 services
Medicare patients, 2024
721
Average age 73
Drug cost, 2024
$6.7M
3,909 prescriptions
Company payments, 2025
$21K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Cheryl K McDonald was code J1569 (injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg), 10,520 times for 14 patients. In total Cheryl K McDonald billed 77,897 services in 58 codes, and Medicare paid $1.5M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-01-21.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 10,520 | 14 | $35.06 | $369K |
| J1459 Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 10,210 | 23 | $37.96 | $388K |
| 99232 Hospital E&M - Subsequent | Facility | 1,211 | 395 | $65.19 | $79K |
| 96366 Intravenous Infusion, Hydration | Office | 660 | 34 | $17.14 | $11K |
| 96365 Intravenous Infusion, Hydration | Office | 615 | 58 | $52.76 | $32K |
| 99233 Hospital E&M - Subsequent | Facility | 368 | 137 | $97.96 | $36K |
| 99214 Office E&M - Established | Office | 266 | 152 | $104.06 | $28K |
| 99222 Hospital E&M - Initial | Facility | 249 | 238 | $109.33 | $27K |
| 99213 Office E&M - Established | Office | 125 | 108 | $70.29 | $8,787 |
| 96375 Injection Administration | Office | 91 | 12 | $12.94 | $1,177 |
| 99223 Hospital E&M - Initial | Facility | 80 | 78 | $143.70 | $11K |
| 99204 Office E&M - New | Office | 43 | 43 | $141.02 | $6,064 |
| 99231 Hospital E&M - Subsequent | Facility | 41 | 35 | $41.39 | $1,697 |
| 99211 Office E&M - Established | Office | 27 | 13 | $18.29 | $494 |
| 36592 Vascular | Office | 26 | 11 | $22.38 | $582 |
By year: 2022 $1.4M for 78,734 services; 2023 $1.5M for 90,268 services; 2024 $1.5M for 77,897 services.
Medicare prescription drug claims, 2024
In 2024, the drug Cheryl K McDonald prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 384 prescriptions and refills. In total Cheryl K McDonald wrote 3,909 Medicare prescriptions that cost $6.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 384 | 390 | 41 | $1.6M |
| Azithromycin Generic | 311 | 381 | 65 | $4,712 |
| Ethambutol Hcl Generic | 236 | 272 | 43 | $10K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 187 | 198 | 19 | $798K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 180 | 182 | 22 | $697K |
| Rifampin Generic | 144 | 169 | 30 | $5,510 |
| Ertapenem Ertapenem Sodium | 90 | 90 | 25 | $36K |
| Voriconazole Generic | 83 | 83 | 21 | $14K |
| Prezcobix Darunavir/Cobicistat | 75 | 81 | Under 11 | $201K |
| Tivicay Dolutegravir Sodium | 65 | 71 | Under 11 | $185K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 60 | 72 | 21 | $1,057 |
| Doxycycline Hyclate Generic | 56 | 58 | 24 | $1,463 |
| Ceftriaxone Ceftriaxone Sodium | 56 | 56 | 17 | $8,161 |
| Atorvastatin Calcium Generic | 54 | 124 | 13 | $428 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 52 | 52 | Under 11 | $196K |
Brand drugs: - claims; generic drugs: 2,425 claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Cheryl K McDonald $21K ($21K in general payments such as food, travel and fees) from 15 companies. The largest payer was Gilead Sciences, Inc. with $19K.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 25 | $19K |
| ViiV Healthcare Company GSK | 31 | $732 |
| Insmed, Inc. INSM | 21 | $474 |
| EMD Serono, Inc. MRK.DE | 10 | $208 |
| Theratechnologies Inc. THTX | 6 | $157 |
| Merck Sharp & Dohme LLC MRK | 7 | $147 |
| Paratek Pharmaceuticals, Inc. | 6 | $123 |
| Abbvie Inc. ABBV | 5 | $89.22 |
| Aimmune Therapeutics, Inc. | 3 | $77.05 |
| Melinta Therapeutics, LLC | 3 | $64.7 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.